From Bethlehem's OraSure Technologies: Some good news on Zika
The company is hard at work on a rapid test for the virus, aided by up to $16.6 million in federal funding.
The company is hard at work on a rapid test for the virus, aided by up to $16.6 million in federal funding.
Like humans, companies start small and evolve. But instead of birth, childhood, adolescence and adulthood, they mature from intellectual capital to incubation, bootstrapping to venture capital, startup to established enterprise. We take a look at that process via four Philly companies.
Researchers at Penn State University have developed a faster and less expensive DNA sequencing method that has led to a surprising finding. The technique works for any species, so it can be used to study male infertility disorders and male-specific mutations.
Tech zillionaire and philanthropist Sean Parker has made a massive contribution to cancer research, establishing the Parker Institute for Cancer Immunotherapy at six of the nation's top medical schools and cancer centers, including the University of Pennsylvania.
This Lehigh Valley entrepreneur struck out on her own, making customized tissue culture media for labs.
This company is hard at work on a revolutionary pharmaceutical that could provide relief to those with mood disorders.
His fast-growing life sciences consultancy provides strategy and solutions for therapies and technologies, from lab to market.
FDA approval is up next for this Italian-born founder of Accel Diagnostics.
Ariotech aims to improve all areas of communication in the healthcare cycle.
Her company's improvements on the monoski are earning attention from those throughout the adaptive winter sports community.